Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors - PubMed (original) (raw)
Review
. 2000 Sep-Oct;381(9-10):827-38.
doi: 10.1515/BC.2000.105.
Affiliations
- PMID: 11076015
- DOI: 10.1515/BC.2000.105
Review
Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors
M Malumbres et al. Biol Chem. 2000 Sep-Oct.
Abstract
Entry into the cell cycle, in particular the G1/S transition, is a tightly regulated process that involves a combination of mitogenic signaling pathways and cell cycle checkpoints. Some of the key regulators of this process are frequently altered in human cancer. Although the proteins that control the G1/S transition have been extensively studied at the biochemical level, little is known regarding their physiological role in vivo. During the last few years, a series of mouse strains carrying gene targeted mutations in key regulators of the G1/S transition have been generated. They include the Rb family of proteins and some of their downstream and upstream regulators. The latter include the regulatory (cyclin) and catalytic (Cdk) subunits of some of the kinases responsible for Rb inactivation as well as all the members of two families of cell cycle inhibitors, the INK4 and the Cip/Kip proteins. In this review, we summarize the most relevant information derived from the characterization of these strains of mice and attempt to integrate it within a functional framework of cell cycle regulation in vivo.
Similar articles
- Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.
Nakayama K, Nakayama K. Nakayama K, et al. Bioessays. 1998 Dec;20(12):1020-9. doi: 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D. Bioessays. 1998. PMID: 10048302 Review. - Ubiquitin-mediated proteolysis of vertebrate G1- and S-phase regulators.
Yew PR. Yew PR. J Cell Physiol. 2001 Apr;187(1):1-10. doi: 10.1002/1097-4652(2001)9999:9999<1::AID-JCP1049>3.0.CO;2-O. J Cell Physiol. 2001. PMID: 11241344 Review. - Small-molecule cyclin-dependent kinase modulators.
Senderowicz AM. Senderowicz AM. Oncogene. 2003 Sep 29;22(42):6609-20. doi: 10.1038/sj.onc.1206954. Oncogene. 2003. PMID: 14528286 Review.
Cited by
- CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism.
Bahn YJ, Yadav H, Piaggi P, Abel BS, Gavrilova O, Springer DA, Papazoglou I, Zerfas PM, Skarulis MC, McPherron AC, Rane SG. Bahn YJ, et al. J Clin Invest. 2023 Jul 3;133(13):e162479. doi: 10.1172/JCI162479. J Clin Invest. 2023. PMID: 37395281 Free PMC article. - MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma.
Fang J, Zhen J, Gong Y, Ke Y, Fu B, Jiang Y, Xie J, Liu Y, Ding Y, Huang D, Xiao F. Fang J, et al. Aging (Albany NY). 2022 Sep 10;14(18):7416-7442. doi: 10.18632/aging.204280. Epub 2022 Sep 10. Aging (Albany NY). 2022. PMID: 36098680 Free PMC article. - Occurrence of senescence-escaping cells in doxorubicin-induced senescence is enhanced by PD0332991, a cyclin-dependent kinase 4/6 inhibitor, in colon cancer HCT116 cells.
Kitada K, Pu F, Toi M. Kitada K, et al. Oncol Lett. 2019 Jan;17(1):1153-1159. doi: 10.3892/ol.2018.9657. Epub 2018 Nov 1. Oncol Lett. 2019. PMID: 30655877 Free PMC article. - miR-708-5p: a microRNA with emerging roles in cancer.
Monteleone NJ, Lutz CS. Monteleone NJ, et al. Oncotarget. 2017 Aug 1;8(41):71292-71316. doi: 10.18632/oncotarget.19772. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050362 Free PMC article. Review. - Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease.
Aguilo F, Di Cecilia S, Walsh MJ. Aguilo F, et al. Curr Top Microbiol Immunol. 2016;394:29-39. doi: 10.1007/82_2015_455. Curr Top Microbiol Immunol. 2016. PMID: 26220772 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources